These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2709485)

  • 1. Antibody response of infants in tropics to five doses of oral polio vaccine.
    Chopra K; Kundu S; Chowdhury DS
    J Trop Pediatr; 1989 Feb; 35(1):19-23. PubMed ID: 2709485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response to three doses of standard and double dose of trivalent oral polio vaccine.
    Agarwal A; Sharma D; Kumari S; Khare S
    Indian Pediatr; 1991 Oct; 28(10):1141-5. PubMed ID: 1665840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
    Asturias EJ; Bandyopadhyay AS; Self S; Rivera L; Saez-Llorens X; Lopez E; Melgar M; Gaensbauer JT; Weldon WC; Oberste MS; Borate BR; Gast C; Clemens R; Orenstein W; O'Ryan G M; Jimeno J; Clemens SA; Ward J; Rüttimann R;
    Lancet; 2016 Jul; 388(10040):158-69. PubMed ID: 27212429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of three doses of oral polio immunization beginning within the first four days of life.
    Bhatawdekar AM; Kumta NB; Dave KH; Bharucha BA
    Indian Pediatr; 1990 Sep; 27(9):911-4. PubMed ID: 2286433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India.
    Mohanty MC; Madkaikar MR; Desai M; Taur P; Nalavade UP; Sharma DK; Gupta M; Dalvi A; Shabrish S; Kulkarni M; Aluri J; Deshpande JM
    Emerg Infect Dis; 2017 Oct; 23(10):1664-1670. PubMed ID: 28930011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of breast-feeding on seroresponse of infants to oral poliovirus vaccination.
    John TJ; Devarajan LV; Luther L; Vijayarathnam P
    Pediatrics; 1976 Jan; 57(1):47-53. PubMed ID: 174056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early immunization of neonates with trivalent oral poliovirus vaccine.
    Weckx LY; Schmidt BJ; Herrmann AA; Miyasaki CH; Novo NF
    Bull World Health Organ; 1992; 70(1):85-91. PubMed ID: 1314711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants.
    Triki H; Abdallah MV; Ben Aissa R; Bouratbine A; Ben Ali Kacem M; Bouraoui S; Koubaa C; Zouari S; Mohsni E; Crainic R; Dellagi K
    Vaccine; 1997 Jul; 15(10):1123-9. PubMed ID: 9269056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune interference of enteroviruses to immune response of TOPV in subtroptical areas].
    Wu CM; Zheng HY; Ren YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Aug; 17(4):233-5. PubMed ID: 9387590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized double-blind controlled clinical trials.
    John TJ; Jain H; Ravishankar K; Amaresh A; Verma H; Deshpande J; Pallansch MA; Singh AP; Sreevatsava M; Burton A; Malankar P; Chatterjee A; Sutter RW
    Vaccine; 2011 Aug; 29(34):5793-801. PubMed ID: 21641951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.
    Hampton LM; Farrell M; Ramirez-Gonzalez A; Menning L; Shendale S; Lewis I; Rubin J; Garon J; Harris J; Hyde T; Wassilak S; Patel M; Nandy R; Chang-Blanc D;
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(35):934-8. PubMed ID: 27606675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, controlled trial of trivalent oral poliovirus vaccine (Sabin) starting at birth in Ghana.
    Osei-Kwasi M; Afari EA; Mimura K; Obeng-Ansah I; Ampofo WK; Nkrumah FK
    Bull World Health Organ; 1995; 73(1):41-6. PubMed ID: 7704924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial.
    Sutter RW; John TJ; Jain H; Agarkhedkar S; Ramanan PV; Verma H; Deshpande J; Singh AP; Sreevatsava M; Malankar P; Burton A; Chatterjee A; Jafari H; Aylward RB
    Lancet; 2010 Nov; 376(9753):1682-8. PubMed ID: 20980048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review.
    Patriarca PA; Wright PF; John TJ
    Rev Infect Dis; 1991; 13(5):926-39. PubMed ID: 1660184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization in India with trivalent and monovalent oral poliovirus vaccines of enhanced potency.
    John TJ; Devarajan LV; Balasubramanyan A
    Bull World Health Organ; 1976; 54(1):115-7. PubMed ID: 1087587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants.
    Steele AD; Reynders J; Scholtz F; Bos P; de Beer MC; Tumbo J; Van der Merwe CF; Delem A; De Vos B
    J Infect Dis; 2010 Sep; 202 Suppl():S93-100. PubMed ID: 20684724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and mucosal immune response to polio vaccination with additional dose in newborn period.
    Bhaskaram P; Nair KM; Hemalatha P; Murthy N; Nair P
    J Trop Pediatr; 1997 Aug; 43(4):232-4. PubMed ID: 9283127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016.
    Immunization Systems Management Group of the Global Polio Eradication Initiative
    MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(25):699-702. PubMed ID: 26135591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.